Respiratory Case Study Patient 1,2,3
Questions And Answers
Chronic nObstructive nPulmonary nDisease n- nAnswer n- nPotential nCondition
Evaluate nLung nFuntion nTests
Evaluate nthe nclient's nmanual ndexterity n- nAnswer n- nActions nto ntake
Do nnot nuse ntiotropium nto nquickly nrelieve nSOB
Suck non nsugarless ncandy nif ndry nmouth noccurs n- nAnswer n- nClient nMedication nEducation
Rationale n- nAnswer n- nRationale:
Chronic nobstructive npulmonary ndisease n(COPD) nis na nchronic, nprogressive, nmostly nirreversible
ncondition nthat nis ncharacterized nby nrestrictions nin nairflow nand ninflammation. nSymptoms ninclude
nchronic ncough, nsputum nproduction, nand ndyspnea. nIt nis nmost ncommonly ncaused nby ncigarette
nsmoking. nThe nclient nhas na nsignificant nsmoking nhistory, nas nevidenced nby n44 nyears nof nsmoking n1
npack nof ncigarettes nper nday. nTherefore, nCOPD nis nthe nmost nlikely ncondition nhe nis nexperiencing,
nparticularly ngiven nhis nsymptoms. nThe nclient's nlung nfunction ntests nwill nbe nevaluated nby nthe
nnurse. nThe nFEV1/FVC nis nless nthan n0.70, nindicating na ndiagnosis nof nCOPD. nAdditionally, nthe
nclient's nFEV1 nof n60% npredicted nsuggests nthe nclient nhas nmoderate nCOPD. nTiotropium nis na nlong-
acting nanticholinergic nbronchodilator nthat nis ngiven nonce ndaily. nThe ndrug nis navailable nas ncapsules,
nwhich nare nplaced ninto na ndry-powder ninhaler ndevice nknown nas na nHandiHaler ndevice. nThe ndevice
nis nactivated nto nrelease nthe ndrug, nwhich nis nthen ninhaled. nThe nnurse nshould nevaluate nthe
nclient's nmanual ndexterity nto nensure nthe ndrug ncan nbe neffectively nadministered. nBecause
ntiotropium nis nan nanticholinergic, ndry nmouth nmay noccur, nwhich ncan nbe nmanaged nby nadvising
nthe nclient nto nsuck non nsugarless ncandy. nBecause ntiotropium nworks nwithin n30 nminutes nof nbeing
nadministered nand nis na nlong-acting ndrug nthat nis nadministered nonce ndaily, nit nshould nnot nbe nused
nto nrelieve nbronchospasms nor nshortness nof nbreath. nThe nclient's nnewly nprescribed nalbuterol
nshould nbe nused nfor nthis nreason. nGiven nthe nclient's nextensive nsmoking nhistory, nhe nprobably
ndoes nnot nhave nasthma. nHaving ndogs nin nhis nhome ncan ncertainly nincrease nthe nrisk nfor nallergic
nrhinitis; nhowever, nhe nhas nsymptoms nthat nare nsuggestive nof nCOPD. nThe nclient nlikely ndoes nnot
Questions And Answers
Chronic nObstructive nPulmonary nDisease n- nAnswer n- nPotential nCondition
Evaluate nLung nFuntion nTests
Evaluate nthe nclient's nmanual ndexterity n- nAnswer n- nActions nto ntake
Do nnot nuse ntiotropium nto nquickly nrelieve nSOB
Suck non nsugarless ncandy nif ndry nmouth noccurs n- nAnswer n- nClient nMedication nEducation
Rationale n- nAnswer n- nRationale:
Chronic nobstructive npulmonary ndisease n(COPD) nis na nchronic, nprogressive, nmostly nirreversible
ncondition nthat nis ncharacterized nby nrestrictions nin nairflow nand ninflammation. nSymptoms ninclude
nchronic ncough, nsputum nproduction, nand ndyspnea. nIt nis nmost ncommonly ncaused nby ncigarette
nsmoking. nThe nclient nhas na nsignificant nsmoking nhistory, nas nevidenced nby n44 nyears nof nsmoking n1
npack nof ncigarettes nper nday. nTherefore, nCOPD nis nthe nmost nlikely ncondition nhe nis nexperiencing,
nparticularly ngiven nhis nsymptoms. nThe nclient's nlung nfunction ntests nwill nbe nevaluated nby nthe
nnurse. nThe nFEV1/FVC nis nless nthan n0.70, nindicating na ndiagnosis nof nCOPD. nAdditionally, nthe
nclient's nFEV1 nof n60% npredicted nsuggests nthe nclient nhas nmoderate nCOPD. nTiotropium nis na nlong-
acting nanticholinergic nbronchodilator nthat nis ngiven nonce ndaily. nThe ndrug nis navailable nas ncapsules,
nwhich nare nplaced ninto na ndry-powder ninhaler ndevice nknown nas na nHandiHaler ndevice. nThe ndevice
nis nactivated nto nrelease nthe ndrug, nwhich nis nthen ninhaled. nThe nnurse nshould nevaluate nthe
nclient's nmanual ndexterity nto nensure nthe ndrug ncan nbe neffectively nadministered. nBecause
ntiotropium nis nan nanticholinergic, ndry nmouth nmay noccur, nwhich ncan nbe nmanaged nby nadvising
nthe nclient nto nsuck non nsugarless ncandy. nBecause ntiotropium nworks nwithin n30 nminutes nof nbeing
nadministered nand nis na nlong-acting ndrug nthat nis nadministered nonce ndaily, nit nshould nnot nbe nused
nto nrelieve nbronchospasms nor nshortness nof nbreath. nThe nclient's nnewly nprescribed nalbuterol
nshould nbe nused nfor nthis nreason. nGiven nthe nclient's nextensive nsmoking nhistory, nhe nprobably
ndoes nnot nhave nasthma. nHaving ndogs nin nhis nhome ncan ncertainly nincrease nthe nrisk nfor nallergic
nrhinitis; nhowever, nhe nhas nsymptoms nthat nare nsuggestive nof nCOPD. nThe nclient nlikely ndoes nnot
